Physician profile
Mary E Bowen
NPI 1659620805
$1,415.68
in general payments reported to CMS, 2019-2025
11 companies · $372 in 2025
The $372 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $119 · 2022: $521 · 2023: $288 · 2024: $115 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $775.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $774.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $400.43 | 2023-2025 | Watchman Flx, General - Ep, Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $297.58 | 2022-2023 | Linq II |
| Impulse Dynamics (USA) INC. | $270.38 | 2021-2023 | Optimizer |
| Philips North America LLC | $159.28 | 2023-2025 | Lm Undivided |
| Abbott Laboratories | $105.61 | 2022-2024 | Mitraclip, Amplatzer Amulet, Jot Dx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $81.07 | 2022 | |
| Atricure, INC. | $29.85 | 2022 | |
| Pfizer INC. | $21.68 | 2021 | |
| Novartis Pharmaceuticals Corporation | $19.55 | 2021 | |
| Merck Sharp & Dohme LLC | $18.18 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $12.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Bowen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.